ALBANO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 13.291
EU - Europa 7.045
AS - Asia 5.472
SA - Sud America 1.402
AF - Africa 309
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 27.526
Nazione #
US - Stati Uniti d'America 13.060
SG - Singapore 2.271
DE - Germania 2.155
IT - Italia 1.629
CN - Cina 1.148
BR - Brasile 1.084
RU - Federazione Russa 918
HK - Hong Kong 705
SE - Svezia 634
GB - Regno Unito 541
VN - Vietnam 363
FR - Francia 332
FI - Finlandia 309
IN - India 191
BD - Bangladesh 180
UA - Ucraina 144
CI - Costa d'Avorio 113
AR - Argentina 110
CA - Canada 107
ID - Indonesia 106
IQ - Iraq 77
ZA - Sudafrica 71
PK - Pakistan 63
MX - Messico 61
JP - Giappone 57
PL - Polonia 56
CO - Colombia 49
TR - Turchia 47
BE - Belgio 43
EC - Ecuador 41
NL - Olanda 40
VE - Venezuela 39
ES - Italia 38
IE - Irlanda 35
AT - Austria 32
SA - Arabia Saudita 31
PH - Filippine 29
CL - Cile 28
TN - Tunisia 28
MA - Marocco 27
CZ - Repubblica Ceca 25
UZ - Uzbekistan 24
MY - Malesia 21
PE - Perù 20
JO - Giordania 18
LT - Lituania 18
NP - Nepal 17
KE - Kenya 15
PY - Paraguay 15
EG - Egitto 14
RO - Romania 14
JM - Giamaica 13
KZ - Kazakistan 13
ET - Etiopia 12
RS - Serbia 12
CH - Svizzera 11
CR - Costa Rica 11
AZ - Azerbaigian 10
KR - Corea 10
PT - Portogallo 10
BO - Bolivia 9
IR - Iran 9
KG - Kirghizistan 9
AE - Emirati Arabi Uniti 8
TH - Thailandia 8
AL - Albania 7
IL - Israele 7
LB - Libano 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
GR - Grecia 6
HN - Honduras 6
BH - Bahrain 5
GT - Guatemala 5
HU - Ungheria 5
NI - Nicaragua 5
PA - Panama 5
SV - El Salvador 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
GE - Georgia 4
HR - Croazia 4
MD - Moldavia 4
MU - Mauritius 4
OM - Oman 4
SN - Senegal 4
AU - Australia 3
BY - Bielorussia 3
CY - Cipro 3
MT - Malta 3
QA - Qatar 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
CG - Congo 2
EE - Estonia 2
GA - Gabon 2
Totale 27.488
Città #
Fairfield 1.541
Ashburn 1.444
Singapore 1.197
Woodbridge 896
Chandler 836
San Jose 790
Houston 725
Hong Kong 699
Seattle 673
Milan 541
Cambridge 530
Nyköping 517
Wilmington 462
New York 393
Beijing 387
Ann Arbor 351
Jacksonville 311
Los Angeles 254
Lauterbourg 205
Rome 186
Lawrence 181
Roxbury 176
Helsinki 165
Bari 146
Dallas 136
Munich 134
Nanjing 117
Abidjan 112
Ho Chi Minh City 109
Council Bluffs 106
Des Moines 106
Brooklyn 105
Boardman 94
Santa Clara 91
Falkenstein 90
São Paulo 85
Princeton 83
Jakarta 79
Columbus 70
Buffalo 63
Inglewood 63
San Diego 63
Hanoi 62
London 60
Moscow 56
Frankfurt am Main 52
Dong Ket 50
Tokyo 49
Figino 48
Paris 47
Warsaw 44
Chicago 43
Brussels 42
Redwood City 38
Rio de Janeiro 38
Atlanta 37
Denver 37
Nanchang 37
Turku 37
Nuremberg 36
Johannesburg 35
Montreal 35
Dublin 33
Belo Horizonte 30
Shenyang 30
Baghdad 29
Chennai 29
Naples 29
Changsha 27
Jiaxing 27
Marseille 27
Turin 27
Dearborn 26
Dhaka 26
Tianjin 26
Boston 25
Pune 25
The Dalles 25
Hebei 24
Orem 24
Guangzhou 23
Mexico City 23
Shanghai 23
Bologna 22
Brasília 22
Phoenix 22
San Francisco 22
Tashkent 22
Toronto 21
Lahore 19
Poplar 18
Curitiba 17
Mumbai 17
Quito 17
Falls Church 16
Portsmouth 16
Salvador 16
Stockholm 16
Campinas 15
Porto Alegre 15
Totale 17.066
Nome #
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. 255
BCR–ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR 252
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome 235
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia. 225
Monosomal karyotype in myeloid neoplasias: a literature review 224
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing 221
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11) 214
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia 213
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies 211
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients 210
A novel fusion 5'AFF3/3'BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma 210
Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA 202
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as a prognostic factor in adult acute promyelocytic leukemia. 202
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia 201
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32) 199
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy 199
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia 198
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia 195
5'RUNX1-3'USP42 chimeric gene in acute myeloid leukemia can occur through an insertion mechanism rather than translocation and may be mediated by genomic segmental duplications. 195
A novel chromosomal translocation t(3;7)(q26;q21)in myeloid leukemia resulting in overexpression of EVI1 192
Molecular cytogenetic study of instability at 1q21∼q32 in adult acute lymphoblastic leukemia 188
Downregulated expression of genes mapping on chromosome 9 in chronic myeloid leukemia cases bearing genomic deletions on der(9) 187
Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology. 187
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1 184
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients 183
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia 181
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 180
A complex and cryptic intrachromosomal rearrangement generating the FIP1L1_PDGFRA in adult acute myeloid leukemia 180
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3 178
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene. 176
Non-treatment-related chronic myeloid leukemia as a second malignancy 175
Pericentric chromosome 8 inversion associated with the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases 170
Decreased TET2 gene expression during chronic myeloid leukemia progression 169
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy, showing gene mutation MYD88 L265P. 169
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 169
Iron chelation therapy induces hematological response in transfusion dependent patient with myeloid malignancies 169
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma 168
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia 168
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene 167
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation? 167
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia 166
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment 164
Concomitant occurrence of BCR-ABL and JAK2V617F mutation 163
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes 163
"Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia 162
Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients 162
Similar mechanisms formed ring markers containing chromosome 12 pericentromeric region in two patients with therapy-related acute myeloid leukemia 161
Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology 160
ABSOLUTE QUANTIFICATION OF THE PRETREATMENT PML-RARA MOLECULAR TRANSCRIPT DEFINES THE RELAPSE RISK IN ACUTE PROMYELOCYTIC LEUKEMIA 160
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma 160
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 159
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 157
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints 156
Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements 156
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 155
RARA and RARG Gene Downregulation Associated with EZH2 Mutation in Acute Promyelocytic-Like Morphology Leukemia 155
Differences among young adults, adults, and elderly chronic myeloid leukemia patients. 155
Next-Generation Sequencing in Acute Lymphoblastic Leukemia 155
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 154
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele 154
Bone marrow ectopic expression of a non-coding RNA in childhood T-cell acute lymphoblastic leukemia with a novel t(2;11)(q11.2;p15.1) translocation 152
Molecular cytogenetic findings supporting the evidence of a biclonal origin in acute myeloid leukemia 151
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma 151
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 151
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 150
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 149
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds? 148
ROLE OF THE TRANSCRIPTION FACTOR CTCF IN THE PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES 146
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 145
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia 144
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house. 144
After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia 144
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a PH-positive chronic myeloid leukemia 143
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience. 143
Chronic Myeloid Leukemia with Variant t(9;22) Shows Dysregulated Expression of Genes Included in Pivotal Cellular Pathways 141
A rare case of IgM-Multiple Myeloma 141
Extramedullary molecular evidence of the 5'KIAA1509/3'PDGFRB fusion gene in chronic eosinophilic leukemia 140
DROPLET DIGITAL PCR ANALYSIS FOR DIAGNOSIS AND MINIMAL RESIDUAL DISEASE MONITORING IN ADULT PH plus ACUTE LYMPHOBLASTIC LEUKEMIA 140
STAT5B GENE DYSREGULATION CORRELATES WITH LEF1 GENE EXPRESSION IN ADULT ACUTE PROMYELOCYTIC LEUKEMIA 140
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile. 138
Submicroscopic deletions in an acute myelocytic leukemia case with a four-way t(8;11;16;21) 138
Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemia 138
FLAG-Ida Regimen as Bridge Therapy to Allotransplantation in Refractory/Relapsed Acute Myeloid Leukemia Patients 138
Retinal abnormalities in newly diagnosed adult acute myeloid leukemia 138
Analysis of percent identity of IGHV mutation as prognostic factor in CLL patients treated with fludarabine, cyclofosfamide and rituximab: a single centre experience 138
Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases 137
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia 137
Concomitant tetrasomy 3q and trisomy 18 in CD5- CD13+ chronic lymphocytic leukemia 136
SETBP1 dysregulation in congenital disorders and myeloid neoplasms 136
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. 136
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP 135
Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia 135
Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link? 133
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients 133
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto 133
Characterization of der(9) deletions in CML patients 132
Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia 132
The Behavior of Cytogenetic/Molecular Markers Associated with JAK2 Mutation Status Before and After Primary Myelofibrosis Progression Supports the Hypothesis of the Leukemic Clone's Independence From the JAK2 Mutation 132
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale 131
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients 130
Totale 16.544
Categoria #
all - tutte 114.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.885


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.410 127 137 19 34 65 132 70 58 122 124 223 299
2022/20232.244 308 307 157 153 228 315 38 270 347 11 49 61
2023/20241.070 79 138 56 58 106 406 24 43 5 29 17 109
2024/20254.090 152 68 263 178 156 339 509 352 185 251 560 1.077
2025/20269.544 1.177 402 613 1.027 1.117 541 1.010 280 1.056 927 305 1.089
2026/2027261 261 0 0 0 0 0 0 0 0 0 0 0
Totale 28.272